GlassScriptPhysician profile
Nicholas P Martin
NPI 1205113040
$10,650.00
in general payments reported to CMS, 2019-2025
32 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,061 · 2022: $2,068 · 2023: $1,891 · 2024: $2,090 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,172 · Consulting Fee: $250 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,171.67 |
| Consulting Fee | $250.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,366.94 | 2021-2025 | Aklief, Epsolay, Oracea |
| Sun Pharmaceutical Industries INC. | $756.90 | 2021-2025 | Winlevi, Absorica Ld |
| Abbvie INC. | $650.99 | 2021-2025 | |
| Amgen INC. | $616.53 | 2021-2025 | Otezla, Otezla |
| Leo Pharma INC. | $560.52 | 2021-2025 | Adbry |
| Mayne Pharma Commercial LLC | $553.25 | 2021-2023 | |
| Ucb, INC. | $516.78 | 2021-2025 | Bimzelx, Cimzia |
| Almirall LLC | $508.41 | 2021-2025 | Klisyri |
| E.R. Squibb & Sons, L.L.C. | $474.23 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $462.50 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $404.74 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $386.10 | 2021-2025 | Cabtreo, Jublia, Siliq |
| Pfizer INC. | $357.56 | 2021-2025 | |
| Lilly USA, LLC | $326.82 | 2021-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $323.54 | 2021-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $318.64 | 2021 | |
| Biofrontera INC. | $281.57 | 2021-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Janssen Biotech, INC. | $261.36 | 2021-2024 | Tremfya, Stelara, Simponi Aria |
| Medimetriks Pharmaceuticals, INC. | $250.00 | 2023 | Neo-Synalar |
| Epi Health, LLC | $238.09 | 2021-2022 | |
| Incyte Corporation | $218.07 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $209.50 | 2021-2022 | |
| Dermavant Sciences, INC. | $205.87 | 2023-2024 | Vtama |
| Verrica Pharmaceuticals INC. | $88.32 | 2023-2025 | Ycanth |
| Intra-Sana Laboratories | $80.53 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Botanix Sb INC | $72.47 | 2025 | Sofdra |
| Journey Medical Corporation | $44.28 | 2022-2024 | |
| Organon LLC | $33.05 | 2025 | Vtama |
| Sebela Pharmaceuticals INC. | $24.80 | 2021 | |
| Fidia Pharma USA INC. | $23.70 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.57 | 2022 | |
| Mission Pharmacal Company | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.